Sep 13, 2022 / 01:05PM GMT
Unidentified Analyst -
We're really excited to have Maravai LifeSciences presenting today and representing the company, we have CEO, Carl Hull; and CFO, Kevin Herde. Kevin, Carl. Welcome.
Carl W. Hull - Maravai LifeSciences Holdings, Inc. - Co-Founder, Chairman & CEO
Thank you, Tom. Good to be here.
Unidentified Analyst -
Great. So I think Carl, you're going to walk us through some summary slides to start, so we can start with that, and then we'll get into some Q&A.
Carl W. Hull - Maravai LifeSciences Holdings, Inc. - Co-Founder, Chairman & CEO
Well, I may be able to do that or I may not because I can't see what the slides are so this could be an interesting presentation. Bottom line, what you see here is that Maravai LifeSciences reagents company providing tools to the industry for a variety of applications. Our businesses is characterized by incredible growth over the last 2 years driven by COVID. You'll see the numbers here for our first half performance in 2022. The growth
Maravai LifeSciences Holdings Inc at Robert W Baird Global Healthcare Conference Transcript
Sep 13, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers